Evotec Se (EVO)

$3.34 -0.03 (-0.89%)
Market Cap 1.25B
Revenue (ttm) 862.40M
Net Income (ttm) -212.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.60%
Debt to Equity Ratio 0.48
Volume 80,500
Avg Vol 195,748
Day's Range N/A - N/A
Shares Out 355.49M
Stochastic %K 9%
Beta 1.81
Analysts Sell
Price Target $5.00

Company Profile

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; centra...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 49 40 560 81 0
Address:
Essener Bogen 7, Hamburg, Germany
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 12:33 PM
$EVO RSI: 46.05, MACD: 0.0154 Vol: 0.11, MA20: 3.60, MA50: 3.41 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 16 at 6:41 PM
$EVO Current Stock Price: $3.52
0 · Reply
ShadowGale
ShadowGale Feb. 4 at 2:08 PM
$EVO is a payment technology and services company; it operates in a consolidating industry and must invest to keep pace with technological change.
0 · Reply
topstockalerts
topstockalerts Feb. 3 at 2:59 PM
$EVO Looks like it wants higher prices. Buyers keep stepping in. This trend is still alive 📈.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 23 at 1:24 PM
$EVO RSI: 66.89, MACD: 0.1133 Vol: 0.26, MA20: 3.42, MA50: 3.20 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 5 at 11:49 PM
$EVO Current Stock Price: $3.19
0 · Reply
CustomsCap
CustomsCap Dec. 25 at 1:09 PM
$EVO Volatility reflects tension between long‑term potential and near‑term uncertainty. Competitive dynamics are compressing the timeline for visible traction. Aligned incentives and governance can stabilize expectations. Risk remains manageable if management converts plans into consistent outputs.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 3:46 PM
$EVO Current Stock Price: $3.10
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 2:21 PM
$EVO Current Stock Price: $2.93
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:09 PM
$BNB.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.,, Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Latest News on EVO
EQS-DD: Evotec SE: Dr. Cord Dohrmann, Disposal of 3653 shares (Sell-to-cover)

2026-01-30T17:14:40.000Z - 25 days ago

EQS-DD: Evotec SE: Dr. Cord Dohrmann, Disposal of 3653 shares (Sell-to-cover)

EQS-DD: Evotec SE: Dr. Cord Dohrmann, Acquisition of 6760 shares due to vesting (Share Performance Plan 2017)

2026-01-30T17:08:36.000Z - 25 days ago

EQS-DD: Evotec SE: Dr. Cord Dohrmann, Acquisition of 6760 shares due to vesting (Share Performance Plan 2017)

EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2026-01-30T14:05:43.000Z - 25 days ago

EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics

2026-01-08T07:56:50.000Z - 6 weeks ago

Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

Thu, 08 Jan 2026 01:50:00 -0500 - 6 weeks ago

Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

Evotec Secures Grant to Use AI for Cost-Effective Monoclonal Antibody Development

2026-01-08T06:35:29.000Z - 6 weeks ago

Evotec Secures Grant to Use AI for Cost-Effective Monoclonal Antibody Development

EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

2026-01-08T06:30:04.000Z - 6 weeks ago

EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

Evotec SE: Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

2026-01-02T05:38:00.000Z - 7 weeks ago

Evotec SE: Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

Fri, 02 Jan 2026 00:30:00 -0500 - 7 weeks ago

Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

Evotec Names Dr. Sarah Fakih as New EVP of Global Communications & IR

2026-01-01T06:35:26.000Z - 7 weeks ago

Evotec Names Dr. Sarah Fakih as New EVP of Global Communications & IR

EQS-News: Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

2026-01-01T06:30:04.000Z - 7 weeks ago

EQS-News: Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations

EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2025-12-29T11:32:53.000Z - 2 months ago

EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS-DD: Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy

2025-12-09T09:40:55.000Z - 2 months ago

EQS-DD: Evotec SE: Prof. Dr. Iris Löw-Friedrich, buy

Evotec: How Low A Company May Go While Still Being Attractive

2025-12-08T09:10:22.000Z - 2 months ago

Evotec: How Low A Company May Go While Still Being Attractive

Sandoz Completes Acquisition Of Just-Evotec Biologics

2025-12-08T06:40:32.000Z - 2 months ago

Sandoz Completes Acquisition Of Just-Evotec Biologics

Evotec SE: Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

2025-12-08T06:26:00.000Z - 2 months ago

Evotec SE: Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

2025-12-08T06:20:00.000Z - 2 months ago

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

Mon, 08 Dec 2025 01:20:00 -0500 - 2 months ago

Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz

Evotec Sells Toulouse Facility to Sandoz: Boosting Evotec Biologics' Growth

2025-12-08T06:05:32.000Z - 2 months ago

Evotec Sells Toulouse Facility to Sandoz: Boosting Evotec Biologics' Growth

EQS-News: Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz

2025-12-08T06:00:03.000Z - 2 months ago

EQS-News: Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

Thu, 04 Dec 2025 02:50:00 -0500 - 2 months ago

Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome

Evotec & Bayer Launch Phase 2 Trial for Alport Syndrome Treatment

2025-12-04T07:35:13.000Z - 2 months ago

Evotec & Bayer Launch Phase 2 Trial for Alport Syndrome Treatment

EQS-News: Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome

2025-12-04T07:30:04.000Z - 2 months ago

EQS-News: Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome

EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2025-11-28T14:26:55.000Z - 3 months ago

EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

2025-11-24T09:39:34.000Z - 3 months ago

EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS-DD: Evotec SE: Wesley Wheeler, buy

2025-11-13T12:20:35.000Z - 3 months ago

EQS-DD: Evotec SE: Wesley Wheeler, buy

Evotec (EVO) Secures $5M Milestone from Bristol Myers Squibb

2025-11-12T08:57:56.000Z - 3 months ago

Evotec (EVO) Secures $5M Milestone from Bristol Myers Squibb

Evotec gets $5M milestone payment from Bristol Myers after FDA accepts new drug application

2025-11-12T08:07:06.000Z - 3 months ago

Evotec gets $5M milestone payment from Bristol Myers after FDA accepts new drug application

Evotec SE: Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

2025-11-12T07:02:00.000Z - 3 months ago

Evotec SE: Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Wed, 12 Nov 2025 02:00:00 -0500 - 3 months ago

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Evotec Hits Milestone with Bristol Myers Squibb in Protein Partnership

2025-11-12T06:39:52.000Z - 3 months ago

Evotec Hits Milestone with Bristol Myers Squibb in Protein Partnership

Evotec SE 2025 Q3 - Results - Earnings Call Presentation

2025-11-07T23:06:00.000Z - 3 months ago

Evotec SE 2025 Q3 - Results - Earnings Call Presentation

EQS-CMS: Evotec SE: Release of a capital market information

2025-11-06T14:35:23.000Z - 3 months ago

EQS-CMS: Evotec SE: Release of a capital market information

Evotec SE (EVOTF) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Cost Reductions ...

2025-11-05T19:01:59.000Z - 3 months ago

Evotec SE (EVOTF) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Cost Reductions ...

Q3 2025 Evotec SE Earnings Call Transcript

2025-11-05T18:10:04.000Z - 3 months ago

Q3 2025 Evotec SE Earnings Call Transcript

Evotec SE (EVO) Q3 2025 Earnings Call Transcript

2025-11-05T17:41:18.000Z - 3 months ago

Evotec SE (EVO) Q3 2025 Earnings Call Transcript

Earnings Scheduled For November 5, 2025

2025-11-05T11:12:12.000Z - 3 months ago

Earnings Scheduled For November 5, 2025

Evotec SE reports Q3 results

2025-11-05T08:29:12.000Z - 3 months ago

Evotec SE reports Q3 results

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

2025-11-05T07:00:00.000Z - 3 months ago

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Wed, 05 Nov 2025 02:00:00 -0500 - 3 months ago

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Evotec SE: Strong 9M 2025 Results with Strategic Focus

2025-11-05T06:35:48.000Z - 3 months ago

Evotec SE: Strong 9M 2025 Results with Strategic Focus

EQS-News: Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities

2025-11-05T06:30:03.000Z - 3 months ago

EQS-News: Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities

Sandoz To Acquire Just-Evotec Biologics EU SAS In Strategic Biosimilars Expansion Deal

2025-11-05T01:45:16.000Z - 3 months ago

Sandoz To Acquire Just-Evotec Biologics EU SAS In Strategic Biosimilars Expansion Deal

Evotec (EVO) Sells Biologics Site to Sandoz for $350M

2025-11-04T23:30:53.000Z - 4 months ago

Evotec (EVO) Sells Biologics Site to Sandoz for $350M

Evotec signs deal with Sandoz for Just - Evotec Biologics site

2025-11-04T22:02:40.000Z - 4 months ago

Evotec signs deal with Sandoz for Just - Evotec Biologics site

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

2025-11-04T21:30:00.000Z - 4 months ago

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

Tue, 04 Nov 2025 16:30:00 -0500 - 4 months ago

In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties

Earnings To Watch: Evotec SE (EVO) Reports Q3 2025 Result

2025-11-04T12:59:17.000Z - 4 months ago

Earnings To Watch: Evotec SE (EVO) Reports Q3 2025 Result

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

Wed, 29 Oct 2025 05:10:00 -0400 - 4 months ago

Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025

Evotec SE to Reveal 9-Month 2025 Results on Nov 5th

2025-10-29T08:50:19.000Z - 4 months ago

Evotec SE to Reveal 9-Month 2025 Results on Nov 5th

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

Oct 27, 2025, 2:50 AM EDT - 4 months ago

Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb

BMY

Evotec SE (EVO) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 2:43 PM EDT - 6 months ago

Evotec SE (EVO) Q2 2025 Earnings Call Transcript

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Aug 13, 2025, 1:25 AM EDT - 6 months ago

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Evotec SE to announce first half-year results 2025 on 13 August 2025

Aug 6, 2025, 4:15 AM EDT - 7 months ago

Evotec SE to announce first half-year results 2025 on 13 August 2025

Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site

Jul 30, 2025, 1:45 AM EDT - 7 months ago

Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site

Jul 30, 2025, 1:40 AM EDT - 7 months ago

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site

Evotec: Recovery Seems To Be Beginning

Jul 23, 2025, 5:43 AM EDT - 7 months ago

Evotec: Recovery Seems To Be Beginning

Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jul 21, 2025, 8:49 AM EDT - 7 months ago

Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session

BULL

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

Jul 21, 2025, 6:10 AM EDT - 7 months ago

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance

Jul 21, 2025, 5:50 AM EDT - 7 months ago

Evotec SE Adjusts Revenue Guidance while Confirming Profit Guidance

Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury

Jun 25, 2025, 1:50 AM EDT - 8 months ago

Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

May 7, 2025, 1:50 AM EDT - 10 months ago

Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments

Evotec SE (EVO) Q1 2025 Earnings Call Transcript

May 6, 2025, 11:15 AM EDT - 10 months ago

Evotec SE (EVO) Q1 2025 Earnings Call Transcript

Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment

May 6, 2025, 1:20 AM EDT - 10 months ago

Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment

Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025

Apr 29, 2025, 4:30 AM EDT - 10 months ago

Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb

Apr 24, 2025, 1:50 AM EDT - 10 months ago

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb

Evotec SE (EVO) Q4 2024 Earnings Call Transcript

Apr 17, 2025, 2:24 PM EDT - 11 months ago

Evotec SE (EVO) Q4 2024 Earnings Call Transcript

Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results

Apr 17, 2025, 1:45 AM EDT - 11 months ago

Evotec SE Unveils New Strategy and Provides 2025 Guidance Bolstered by Strong Q4 2024 Results

Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025

Apr 10, 2025, 6:00 AM EDT - 11 months ago

Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

Mar 4, 2025, 1:45 AM EST - 1 year ago

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

BMY

Evotec Announces Change in Management Board

Feb 26, 2025, 2:00 AM EST - 1 year ago

Evotec Announces Change in Management Board

Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner

Feb 19, 2025, 7:55 AM EST - 1 year ago

Advancing Data Centric AI in Healthcare and Life Sciences - Elucidata Onboards Former CEO of Evotec and Ex-McKinsey Senior Partner

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

Jan 22, 2025, 2:00 AM EST - 1 year ago

Evotec Receives Grant from Korean Government to Develop Novel Antibody-based Treatments for Lung Diseases

Evotec: Some Recovery Has Come, But Much More Is Expected

Dec 29, 2024, 12:30 PM EST - 1 year ago

Evotec: Some Recovery Has Come, But Much More Is Expected

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

Dec 11, 2024, 2:00 AM EST - 1 year ago

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk

Comment on Withdrawn Non-Binding Offer

Nov 22, 2024, 11:15 AM EST - 1 year ago

Comment on Withdrawn Non-Binding Offer

Halozyme withdraws $2.1 bln buyout offer for Evotec

Nov 22, 2024, 8:55 AM EST - 1 year ago

Halozyme withdraws $2.1 bln buyout offer for Evotec

HALO

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions

Nov 22, 2024, 8:35 AM EST - 1 year ago

Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions

HALO

Halozyme CEO: Evotec Is Poised for Growth

Nov 18, 2024, 4:00 PM EST - 1 year ago

Halozyme CEO: Evotec Is Poised for Growth

HALO

Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec

Nov 18, 2024, 7:00 AM EST - 1 year ago

Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec

HALO

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

Nov 15, 2024, 12:56 PM EST - 1 year ago

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion

HALO

Comment on Media Report

Nov 14, 2024, 5:30 PM EST - 1 year ago

Comment on Media Report

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction

Nov 14, 2024, 4:15 PM EST - 1 year ago

Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction

HALO

Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports

Nov 14, 2024, 4:09 PM EST - 1 year ago

Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports

HALO

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal

Nov 11, 2024, 10:52 AM EST - 1 year ago

Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal

Evotec SE (EVO) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 7:11 PM EST - 1 year ago

Evotec SE (EVO) Q3 2024 Earnings Call Transcript

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

Nov 6, 2024, 1:20 AM EST - 1 year ago

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

Nov 5, 2024, 1:50 AM EST - 1 year ago

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

Oct 30, 2024, 3:30 AM EDT - 1 year ago

Evotec SE to Announce Results for the First Nine Months 2024 on 06 November 2024

Evotec and Bristol Myers Squibb Expand Proteomics Partnership

Oct 23, 2024, 2:00 AM EDT - 1 year ago

Evotec and Bristol Myers Squibb Expand Proteomics Partnership

OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 23 at 12:33 PM
$EVO RSI: 46.05, MACD: 0.0154 Vol: 0.11, MA20: 3.60, MA50: 3.41 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 16 at 6:41 PM
$EVO Current Stock Price: $3.52
0 · Reply
ShadowGale
ShadowGale Feb. 4 at 2:08 PM
$EVO is a payment technology and services company; it operates in a consolidating industry and must invest to keep pace with technological change.
0 · Reply
topstockalerts
topstockalerts Feb. 3 at 2:59 PM
$EVO Looks like it wants higher prices. Buyers keep stepping in. This trend is still alive 📈.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 23 at 1:24 PM
$EVO RSI: 66.89, MACD: 0.1133 Vol: 0.26, MA20: 3.42, MA50: 3.20 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 5 at 11:49 PM
$EVO Current Stock Price: $3.19
0 · Reply
CustomsCap
CustomsCap Dec. 25 at 1:09 PM
$EVO Volatility reflects tension between long‑term potential and near‑term uncertainty. Competitive dynamics are compressing the timeline for visible traction. Aligned incentives and governance can stabilize expectations. Risk remains manageable if management converts plans into consistent outputs.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 3:46 PM
$EVO Current Stock Price: $3.10
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 2:21 PM
$EVO Current Stock Price: $2.93
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:09 PM
$BNB.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.,, Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:08 PM
$BCH.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:07 PM
$BAT.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:07 PM
$BAC This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.,. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:06 PM
$BABA This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility., Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:06 PM
$BA This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
2 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:05 PM
$B This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:05 PM
$AMP.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:04 PM
$ALGO.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.... Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:04 PM
$ACH.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:03 PM
$ADA.X This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:03 PM
$AMZN This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility.. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply
Alarusso68
Alarusso68 Dec. 8 at 4:02 PM
$AMD This week we released the new tier system and activated token-gated access for the $EVO bot. Next, we’ll be working on the $EVO Credit System, where users will earn $EVO credits based on their holdings. Overall, it was a solid week, the market is rising again, and we’re gearing up to become the next major on-chain utility. Stay tuned; there’s much more coming Our vision is simple: transform raw blockchain data into intelligence that empowers smarter, safer, and more confident decisions. This is where innovation meets precision. This is Envion AI crypto on Ethereum. Buy while its still low!!! C/A 0x61577e532d850dc7d6a8a81bcb945c01ba33a457
0 · Reply